Literature DB >> 16132279

Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease.

Y Ikemoto1, H Ogino, M Teraguchi, Y Kobayashi.   

Abstract

Cardiac sequelae of Kawasaki disease are an important cause of ischemic heart disease in young adults. The possibility of early progression of atherosclerosis following Kawasaki disease is therefore of great concern. We examined whether preclinical atherosclerotic changes are seen in patients with a history of Kawasaki disease, and whether these changes appear in all or in only a proportion of patients. Sixty-five patients with a history of Kawasaki disease, aged 13.1 +/- 2.1 years, and 20 aged-matched controls participated in the study. All subjects underwent flow-mediated dilatation (FMD) of the brachial artery and analysis of carotid artery size and pulse-wave transmission. Patients were classified into four groups depending on the severity of the maximum coronary artery lesion: group 0 (normal), group 1 (mild), group 2 (moderate), and group 3 (severe). There was no statistical difference in the carotid artery analyses between the four groups. FMD (mean +/- SD) was significantly lower in groups 2 and 3 than in groups 0 and 1 and the control group (group 0, 19.4 +/- 3.9%; group 1, 19.5 +/-4.1%; group 2, 8.9 +/- 2.8%; group 3, 4.2 +/- 1.5%; control group, 18.8 +/- 2.8%; p < 0.0001). There was a significantly negative correlation between the severity of the coronary artery lesion and FMD (p < 0.0001 for both). Endothelial dysfunction was revealed by FMD in patients with persistent coronary artery lesions subsequent to Kawasaki disease. Preclinical atherosclerosis may be present only in patients with coronary aneurysms.

Entities:  

Mesh:

Year:  2005        PMID: 16132279     DOI: 10.1007/s00246-005-0921-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  Endothelial dysfunction late after Kawasaki disease.

Authors:  R Dhillon; P Clarkson; A E Donald; A J Powe; M Nash; V Novelli; M J Dillon; J E Deanfield
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

3.  Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine.

Authors:  R Yamakawa; M Ishii; T Sugimura; T Akagi; G Eto; M Iemura; T Tsutsumi; H Kato
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

4.  Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging.

Authors:  S Schroeder; M D Enderle; R Ossen; C Meisner; A Baumbach; M Pfohl; C Herdeg; M Oberhoff; H U Haering; K R Karsch
Journal:  Am Heart J       Date:  1999-10       Impact factor: 4.749

5.  Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound.

Authors:  M C Corretti; G D Plotnick; R A Vogel
Journal:  Am J Physiol       Date:  1995-04

6.  Fate of coronary arterial aneurysms in Kawasaki disease.

Authors:  A Suzuki; T Kamiya; Y Arakaki; Y Kinoshita; K Kimura
Journal:  Am J Cardiol       Date:  1994-10-15       Impact factor: 2.778

7.  Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease.

Authors:  J T Kuvin; A R Patel; K A Sliney; N G Pandian; W M Rand; J E Udelson; R H Karas
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

8.  Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease.

Authors:  T Neunteufl; R Katzenschlager; A Hassan; U Klaar; S Schwarzacher; D Glogar; P Bauer; F Weidinger
Journal:  Atherosclerosis       Date:  1997-02-28       Impact factor: 5.162

9.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

10.  Differentiation of embolic and thrombotic middle cerebral artery occlusion using ultrasonic carotid flow velocity analysis.

Authors:  T Urabe; N Shioya-Morikawa
Journal:  J Neurol Sci       Date:  1995-02       Impact factor: 3.181

View more
  23 in total

1.  Endothelial dysfunction in adult patients with a history of Kawasaki disease.

Authors:  Ayumi Niboshi; Kenji Hamaoka; Koichi Sakata; Nozomi Yamaguchi
Journal:  Eur J Pediatr       Date:  2007-03-08       Impact factor: 3.183

2.  Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.

Authors:  Chao Duan; Zhong-Dong Du; Yu Wang; Li-Qun Jia
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

3.  Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease.

Authors:  Y-f Cheung; S J Wong; M H K Ho
Journal:  Arch Dis Child       Date:  2006-07-04       Impact factor: 3.791

4.  The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Authors:  S Blankier; B W McCrindle; S Ito; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

5.  Mid-term Risk for Subclinical Atherosclerosis and Chronic Myocarditis in Children with Kawasaki Disease and Transient Coronary Abnormalities.

Authors:  Mansingh Parihar; Surjit Singh; Pandiarajan Vignesh; Anju Gupta; Manojkumar Rohit
Journal:  Pediatr Cardiol       Date:  2017-05-17       Impact factor: 1.655

Review 6.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

7.  Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia.

Authors:  Veerapol Kukongviriyapan; Nuntiya Somparn; Laddawan Senggunprai; Auemduan Prawan; Upa Kukongviriyapan; Arunee Jetsrisuparb
Journal:  Pediatr Cardiol       Date:  2007-09-22       Impact factor: 1.655

8.  High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease.

Authors:  Arturo Borzutzky; Miguel Gutiérrez; Eduardo Talesnik; Iván Godoy; Jonathan Kraus; Rodrigo Hoyos; Pilar Arnaiz; Mónica Acevedo
Journal:  Clin Rheumatol       Date:  2007-12-11       Impact factor: 2.980

9.  First report on the lipid profile late after kawasaki disease in Iranian children.

Authors:  Seyyed-Naserredin Mostafavi; Elham Barzegar; Nayereh Siyah Manssori; Roya Kelishadi
Journal:  Int J Prev Med       Date:  2014-07

10.  Carotid intima-media thickness and pulse wave velocity after recovery from kawasaki disease.

Authors:  Soo Jin Lee; Hye Mi Ahn; Jung Hyun You; Young Mi Hong
Journal:  Korean Circ J       Date:  2009-07-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.